PATENT CLAIM ANALYSIS

Application Number: 15962982
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "256000"]

Abstract:
The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

Claim (Index 17):
A method of treating or preventing pain or inflammation in a patient in need thereof comprising administration of an effective amount of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-citrate to the patient in need thereof.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 91.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13129898', '14074147', '15354832', '15539147', '15622544']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7530852257912906
- 35 USC 102 Novelty (BERT): 0.5990586697185336
- Combined Prediction Score: 0.737682570184015
- Mean Citation Score: 410.296236
- Max Citation Score: 578.8974599999998
- Similarity Product: 439.4050847329688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test